ESMO scientific and educational resources on this topic
Recent medwireNews and resources from conferences are for ESMO Members only.
Tumour Sites: Gynaecological Malignancies
Gynaecological Tumours
Clinical Practice Guidelines
Latest ESMO videos
Featured medwireNews
Incorporating Veliparib into Chemotherapy and Continuing with Veliparib Maintenance Significantly Improved PFS in Newly Diagnosed High-Grade Serous Ovarian Cancer
Niraparib Prolongs PFS in Patients with Newly Diagnosed Advanced Ovarian Cancer
Breakthrough from PAOLA1 GINECO/ENgOT-ov25 trial: Adding Olaparib to Bevacizumab Maintenance Demonstrates Substantial Clinical Benefit in Newly Diagnosed Advanced Ovarian Cancer
KEYNOTE-158 Suggests Pembrolizumab Activity For PD-L1-Positive Cervical Cancer
Olaparib Maintenance ‘Substantial Benefit’ For Advanced BRCA-Positive Ovarian Cancer
E-Learning
ESMO E-Learning: Ovarian Cancer IP Chemotherapy
ESMO E-Learning: Management of BRCA Mutated Ovarian Cancer
ESMO E-Learning: Targeting Angiogenesis in Ovarian Cancer
Factsheets on Biomarkers
Microsatellite Instability - Defective DNA Mismatch Repair: ESMO Biomarker Factsheet
BRCA1 and BRCA2 in Ovarian Cancer: ESMO Biomarker Factsheet
Meeting resources
ESMO Congress
ESMO Asia Congress 2019
Singapore
ESMO Congress
ESMO Congress 2019
Barcelona
ESMO Course
ESMO Academy 2019
Oxford
ESMO Conference
ESMO Summit Russia 2019
Kazan
ESMO Course
ESMO Preceptorship on Hereditary Cancer Genetics Lugano April 2019
Lugano